TR200102557T2 - Tiazonlindolinon bileşikleri. - Google Patents

Tiazonlindolinon bileşikleri.

Info

Publication number
TR200102557T2
TR200102557T2 TR2001/02557T TR200102557T TR200102557T2 TR 200102557 T2 TR200102557 T2 TR 200102557T2 TR 2001/02557 T TR2001/02557 T TR 2001/02557T TR 200102557 T TR200102557 T TR 200102557T TR 200102557 T2 TR200102557 T2 TR 200102557T2
Authority
TR
Turkey
Prior art keywords
thiazonlindolinone
compounds
thiazole
severity
inhibitors
Prior art date
Application number
TR2001/02557T
Other languages
English (en)
Turkish (tr)
Inventor
Vyas Ambrish
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200102557T2 publication Critical patent/TR200102557T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
TR2001/02557T 1999-03-04 2000-03-01 Tiazonlindolinon bileşikleri. TR200102557T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9904930.6A GB9904930D0 (en) 1999-03-04 1999-03-04 Thiazoloindolinone compounds

Publications (1)

Publication Number Publication Date
TR200102557T2 true TR200102557T2 (tr) 2007-01-22

Family

ID=10848912

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02557T TR200102557T2 (tr) 1999-03-04 2000-03-01 Tiazonlindolinon bileşikleri.

Country Status (18)

Country Link
EP (1) EP1159280A2 (xx)
JP (1) JP2003532620A (xx)
KR (1) KR20020005606A (xx)
CN (1) CN1355807A (xx)
AU (1) AU3611000A (xx)
BR (1) BR0008677A (xx)
CA (1) CA2361580A1 (xx)
CZ (1) CZ20013187A3 (xx)
GB (1) GB9904930D0 (xx)
HK (1) HK1041692A1 (xx)
HU (1) HUP0200376A3 (xx)
IL (1) IL144808A0 (xx)
MX (1) MXPA01008910A (xx)
NO (1) NO20014262L (xx)
PL (1) PL351476A1 (xx)
TR (1) TR200102557T2 (xx)
WO (1) WO2000052013A2 (xx)
ZA (1) ZA200106826B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
TWI315310B (en) * 2004-12-01 2009-10-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods of preparing pimecrolimus
UA103319C2 (xx) * 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Сполуки бензенсульфонамідтіазолу та -оксазолу$соединения бензенсульфонамидтиазола и -оксазола
EP2554184B1 (en) 2010-03-31 2016-10-26 ONO Pharmaceutical Co., Ltd. Preventive and/or remedy for hand and foot syndrome
JP4761000B1 (ja) * 2010-11-08 2011-08-31 小野薬品工業株式会社 手足症候群の予防および／または治療剤
TW201927292A (zh) 2017-12-13 2019-07-16 大陸商上海小午醫藥科技有限公司 一種用於預防或治療與ｅｇｆｒ被抑制相關疾病的方法
CN114028568A (zh) 2018-04-16 2022-02-11 上海岸阔医药科技有限公司 预防或治疗肿瘤疗法副作用的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289102A1 (en) * 1997-05-07 1998-11-12 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives

Also Published As

Publication number Publication date
BR0008677A (pt) 2002-01-08
CA2361580A1 (en) 2000-09-08
HUP0200376A2 (en) 2002-06-29
EP1159280A2 (en) 2001-12-05
NO20014262D0 (no) 2001-09-03
WO2000052013A2 (en) 2000-09-08
AU3611000A (en) 2000-09-21
JP2003532620A (ja) 2003-11-05
PL351476A1 (en) 2003-04-22
WO2000052013A3 (en) 2000-12-28
CN1355807A (zh) 2002-06-26
HK1041692A1 (zh) 2002-07-19
IL144808A0 (en) 2002-06-30
GB9904930D0 (en) 1999-04-28
ZA200106826B (en) 2003-02-25
KR20020005606A (ko) 2002-01-17
NO20014262L (no) 2001-10-30
CZ20013187A3 (cs) 2002-02-13
HUP0200376A3 (en) 2003-07-28
MXPA01008910A (es) 2002-03-27

Similar Documents

Publication Publication Date Title
NO20032759D0 (no) 2-fenylbenzimidazoler og imidazo-[4,5]-pyridiner som SDSI/CHK2-inhibitorerog adjuvanter ved kjemoterapi eller strålingsterapi ved behandlingav kreft
MY138059A (en) Use of ikb-kinase inhibitors in pain therapy
AP1913A (en) Substituted benzazoles and use thereof as raf kinase inhibitors
TR200102020T2 (tr) Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler.
EA200101166A1 (ru) Ингибиторы металлопротеаз
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
GEP20033092B (en) Purine Inhibitors of Cyclin Dependent Kinase 2 and Ik-Aa
TR200200160T2 (tr) Antiinflamatuar ajanlar olarak imidazoller ve triazoller
RS48804A (xx) Aril urea jedinjenja u kombinaciji sa drugim citostatičkim ili citotoksičnim agensima za tretiranje humanih kancera
NO20072654L (no) Cancer behandling
ATE363896T1 (de) Gegen missbrauch gesicherte darreichungsform
UA84954C2 (ru) Конденсированные пиримидоны, пригодные для лечения и профилактики злокачественного новообразования
EA200801430A1 (ru) Производные триазола
NO20051040L (no) Anvendelse av alkylfosfokoliner i kombinasjon med antitumormedikamenter
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
NO20024076L (no) Sammensetning omfattende camptotecin og et pyrimidinderivat for behandling av cancer
TR200103271T2 (tr) İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi.
BR0315942A (pt) Tratamento de doenças e condições mediadas pelo aumento de fosforilação
TR200102557T2 (tr) Tiazonlindolinon bileşikleri.
DE602005027739D1 (de) Arylsubstituiertes benzimidazol- und imidazopyridinether als wirkstoffe gegen krebs
TR200101693T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
DK1558620T3 (da) Rutheniumkomplekser med anticancervirkning
ATE269313T1 (de) Tryptase-inhibitoren
ATE268322T1 (de) Inhibitoren der tryptase
IL164356A0 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy